Latest Articles

Publication Date
Mismatch Repair Protein Expression in Endometrial Intraepithelial Neoplasia and Endometrial Carcinoma: Experience From a Tertiary Care Hospital - Cureus

Mismatch Repair Protein Expression in Endometrial Intraepithelial Neoplasia and Endometrial Carcinoma: Experience From a Tertiary Care Hospital Cureus

Published: Aug. 26, 2026, 12:53 a.m.
A novel tRNA-derived fragment, tRF-19-79MP9PJZ, promotes uterine corpus endometrial carcinoma progression by targeting DSC3.

Uterine corpus endometrial carcinoma (UCEC) ranks as the 6th most common malignancy among women. Emerging evidence indicates that the dysregulation of tRNA-derived fragments (tRFs) is involved in the pathogenesis of …

Published: Aug. 6, 2026, midnight
Risk of Concurrent Endometrial Carcinoma in Patients Diagnosed With Atypical Endometrial Hyperplasia: A Retrospective Observational Study - Cureus

Risk of Concurrent Endometrial Carcinoma in Patients Diagnosed With Atypical Endometrial Hyperplasia: A Retrospective Observational Study Cureus

Published: July 5, 2026, 4:45 a.m.
Cholesteryl Ester Accumulation as a Biomarker for Personalized Selection of Fertility-Preserving Therapies in Endometrioid Endometrial Carcinoma - EurekAlert!

Cholesteryl Ester Accumulation as a Biomarker for Personalized Selection of Fertility-Preserving Therapies in Endometrioid Endometrial Carcinoma EurekAlert!

Published: June 22, 2026, 7:37 p.m.
The significance of retroperitoneal lymph node dissection in stage 1 endometrial carcinoma: A... - Medical Dialogues

The significance of retroperitoneal lymph node dissection in stage 1 endometrial carcinoma: A... Medical Dialogues

Published: June 22, 2026, 5:15 a.m.
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation - Cureus

Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation Cureus

Published: June 11, 2026, 8:19 a.m.
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma - Cureus

Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma Cureus

Published: May 31, 2026, 4:44 p.m.
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma Nature

Published: May 8, 2026, 3:28 p.m.
Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively - Cureus

Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively Cureus

Published: May 6, 2026, 9:16 a.m.
Evaluation of Ki-67 Expression in Disordered Proliferative Endometrium, Endometrial Hyperplasia, and Endometrial Carcinoma - Cureus

Evaluation of Ki-67 Expression in Disordered Proliferative Endometrium, Endometrial Hyperplasia, and Endometrial Carcinoma Cureus

Published: April 28, 2026, 10:12 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!